ReNeuron Group plc
07 December 2006
Director Share Purchases
Guildford, UK, 6 December 2006: ReNeuron Group plc (LSE: RENE) today announces
the following purchases of ordinary shares in ReNeuron by directors of the
Company at 19.5p per share.
Name Number of Shares Purchased
Michael Hunt 51500
John Sinden 36000
Mark Docherty 51400(1)
Trevor Jones 25700
Paul Harper 57500
Following these purchases the directors of ReNeuron have the following interests
in issued ordinary shares in ReNeuron:
Name Number of shares Percentage of issued share
capital
Michael Hunt 174,613 0.18%
John Sinden 1,219,925(2) 1.22%
Mark Docherty 146,400(3) 0.15%
Trevor Jones 83,200 0.08%
Paul Harper 83,200 0.08%
The current issued ordinary share capital of the Company is 99,604,700 shares.
(1) = including 24,700 ordinary shares acquired by the MD FURBS, a funded
unapproved retirement benefit scheme established by Mark Docherty
(2) = in addition John Sinden holds 117,160 ordinary shares on trust for
family members
(3) = including 120,700 ordinary shares held by the MD FURBS, a funded
unapproved retirement benefit scheme established by Mark Docherty
ENDS
Enquiries:
ReNeuron
Michael Hunt, CEO Tel: 44 (0)1483 302 560
John Sinden, CSO
Financial Dynamics
David Yates Tel: 44 (0)20 7831 3113
Nicola Daley
This information is provided by RNS
The company news service from the London Stock Exchange ND
RDSILFFAFFLRIIR
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.